In Vitro and in Silico studies to explore structural features of flavonoids for aldehyde oxidase inhibition

Archiv der Pharmazie

Volumn 347, Issue 10, 2014, Pages 738-747

  Hamzeh Mivehroud, Maryam ^a,b   Rahmani, Seifullah ^c   Feizi, Mohammad Ali Hosseinpour ^c   Dastmalchi, Siavoush ^a,b   Rashidi, Mohammad Reza ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TABRIZ   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aldehyde oxidase; Enzyme inhibition; Molecular docking; QSAR; Vanillin

Indexed keywords

ALDEHYDE; ALDEHYDE OXIDASE; CATECHIN; DAIDZEIN; EPICATECHIN; FLAVONOID; GENISTEIN; HESPERETIN; HESPERIDIN; HETEROCYCLIC AMINE; HYPERIN; MORIN; MYRICETIN; NARINGENIN; PHENANTHRIDINE DERIVATIVE; QUERCETIN; VANILLIN; VITEXIN; ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; COMPUTER MODEL; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME METABOLISM; FOOD DRUG INTERACTION; IC50; IN VITRO STUDY; MALE; MOLECULAR DOCKING; NONHUMAN; PREDICTION; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; SPECTROPHOTOMETRY; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; COMPUTER AIDED DESIGN; DRUG DESIGN; DRUG EFFECTS; ENZYMOLOGY; LIVER; METABOLISM; MOLECULAR DYNAMICS; PROTEIN CONFORMATION; SPRAGUE DAWLEY RAT;

ALDEHYDE OXIDASE; ANIMALS; COMPUTER-AIDED DESIGN; DRUG DESIGN; ENZYME INHIBITORS; FLAVONOIDS; LIVER; MALE; MOLECULAR DYNAMICS SIMULATION; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS, SPRAGUE-DAWLEY;

EID: 84908017959     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201400076     Document Type: Article

References (72)

1. J. A. Yáñez, N. V. Chemuturi, S. W. Womble, C. L. Sayre, N. M. Davies, in Flavonoid Pharmacokinetics: Methods of Analysis, Preclinical and Clinical Pharmacokinetics, Safety, and Toxicology (Eds: N. M. Davies, J. A. Yáñez), John Wiley & Sons, New Jersey 2013, pp. 281-319.
2. S. E. Clarke, A. W. Harrell, R. J. Chenery, Drug Metab. Dispos. 1995, 23, 251-254.
3. C. G. Jordan, M. R. Rashidi, H. Laljee, S. E. Clarke, J. E. Brown, C. Beedham, J. Pharm. Pharmacol. 1999, 51, 411-418.
4. M. R. Rashidi, C. Beedham, J. S. Smith, S. Davaran, Drug Metab. Pharmacokinet. 2007, 22, 299-306.
5. Y. Moriwaki, T. Yamamoto, J. Yamakita, S. Takahashi, Z. Tsutsumi, K. Higashino, Adv. Exp. Med. Biol. 1998, 431, 47-50.
6. A. B. Renwick, S. E. Ball, J. M. Tredger, R. J. Price, D. G. Walters, J. Kao, J. A. Scatina, B. G. Lake, Xenobiotica 2002, 32, 849-862.
7. M. R. Rashidi, H. Nazemiyeh, Expert Opin. Drug Metab. Toxicol. 2010, 6, 133-152.
8. A. Kralj, M.-T. Nguyen, N. Tschammer, N. Ocampo, Q. Gesiotto, M. R. Heinrich, O. Phanstiel, J. Med. Chem. 2013, 56, 5019-5032.
9. H. L. Liu, W. B. Jiang, M. X. Xie, Recent Pat Anticancer Drug Discov. 2010, 5, 152-164.
10. L. Mira, L. Maia, L. Barreira, C. F. Manso, Arch. Biochem. Biophys. 1995, 318, 53-58.
11. T. K. Kundu, R. Hille, M. Velayutham, J. L. Zweier, Arch. Biochem. Biophys. 2007, 460, 113-121.
12. R. Hille, Trends Biochem. Sci. 2002, 27, 360-367.
13. V. J. Feron, H. P. Til, F. de Vrijer, R. A. Woutersen, F. R. Cassee, P. J. van Bladeren, Mutat. Res. 1991, 259, 363-385.
14. R. Lindahl, Crit. Rev. Biochem. Mol. Biol. 1992, 27, 283-335.
15. C. Beedham, C. F. Peet, G. I. Panoutsopoulos, H. Carter, J. A. Smith, Prog. Brain Res. 1995, 106, 345-353.
16. G. I. Panoutsopoulos, D. Kouretas, E. G. Gounaris, C. Beedham, Eur. J. Drug Metab. Pharmacokinet. 2004, 29, 111-118.
17. K. Washio, O. Makaya, H. Sasaki, K. Nishida, J. Nakamura, J. Shibasaki, J. Pharm. Pharmacol. 1993, 45, 231-233.
18. G. I. Panoutsopoulos, C. Beedham, Acta Biochim. Pol. 2004, 51, 649-663.
19. G. I. Panoutsopoulos, D. Kouretas, C. Beedham, Chem. Res. Toxicol. 2004, 17, 1368-1376.
20. K. Yamanaka, H. Iino, T. Oikawa, Agric. Biol. Chem. 1991, 55, 989-996.
21. A. K. Sinha, U. K. Sharma, N. Sharma, Int. J. Food Sci. Nutr. 2008, 59, 299-326.
22. N. J. Walton, M. J. Mayer, A. Narbad, Phytochemistry 2003, 63, 505-515.
23. M. Hamzeh-Mivehroud, S. Rahmani, M. R. Rashidi, M. A. Hosseinpour Feizi, S. Dastmalchi, Xenobiotica 2013, 43, 661-670.
24. M. H. Sorouraddin, E. Fooladi, A. Naseri, M. R. Rashidi, J. Biochem. Biophys. Methods 2008, 70, 999-1005.
25. M. Saquib, M. K. Gupta, R. Sagar, Y. S. Prabhakar, A. K. Shaw, R. Kumar, P. R. Maulik, A. N. Gaikwad, S. Sinha, A. K. Srivastava, V. Chaturvedi, R. Srivastava, B. S. Srivastava, J. Med. Chem. 2007, 50, 2942-2950.
26. R. Todeschini, V. Consonni, in Handbook of Molecular Descriptors, (Eds: R. Mannhold, H. Kubinyi, H. Timmerman), Wiley-VCH, Weinheim 2000.
27. A. G. Mercader, P. R. Duchowicz, F. M. Fernandez, E. A. Castro, D. O. Bennardi, J. C. Autino, G. P. Romanelli, Bioorg. Med. Chem. 2008, 16, 7470-7476.
28. V. Consonni, R. Todeschini, M. Pavan, J. Chem. Inf. Comput. Sci. 2002, 42, 682-692.
29. V. Consonni, R. Todeschini, M. Pavan, P. Gramatica, J. Chem. Inf. Comput. Sci. 2002, 42, 693-705.
30. M. P. Gonzalez, C. Teran, M. Teijeira, P. Besada, Bioorg. Med. Chem. Lett. 2005, 15, 2641-2645.
31. M. P. Gonzalez, C. Teran, M. Teijeira, M. J. Gonzalez-Moa, Eur. J. Med. Chem. 2005, 40, 1080-1086. Epub 2005 July 11.
32. L. Saiz-Urra, M. P. Gonzalez, Y. Fall, G. Gomez, Eur. J. Med. Chem. 2007, 42, 64-70. Epub 2006 October 9.
33. A. M. Helguera, M. N. Cordeiro, M. A. Perez, R. D. Combes, M. P. Gonzalez, Bioorg. Med. Chem. 2008, 16, 3395-3407. Epub November 17. DOI: 10.1016/j.bmc.2007.11.029
34. P. Broto, G. Moreau, C. Vandycke, Eur. J. Med. Chem. 1984, 19, 66-70.
35. G. Moreau, P. Broto, Nouv. J. Chim. 1980, 4, 359-360.
36. G. Moreau, P. Broto, Nouv. J. Chim. 1980, 4, 757-764.
37. A. Saklani, S. K. Kutty, Drug Discov. Today 2008, 13, 161-171.
38. M. S. Butler, J. Nat. Prod. 2004, 67, 2141-2153.
39. R. Schneider-Stock, I. H. Fakhoury, A. M. Zaki, C. O. El-Baba, H. U. Gali-Muhtasib, Drug Discov. Today 2014, 19, 18-30.
40. L. T. Tan, Drug Discov. Today 2013, 18, 863-871.
41. D. G. Brown, T. Lister, T. L. May-Dracka, Bioorg. Med. Chem. Lett. 2014, 24, 413-418.
42. T. Wu, M. He, X. Zang, Y. Zhou, T. Qiu, S. Pan, X. Xu, Biochim. Biophys. Acta 2013, 1828, 2751-2756.
43. T. P. T. Cushnie, A. J. Lamb, Int. J. Antimicrob. Agents 2005, 26, 343-356.
44. W. Huang, Q. Chen, W. C. Yang, G. F. Yang, Eur. J. Med. Chem. 2013, 66, 161-170.
45. K. E. Heim, A. R. Tagliaferro, D. J. Bobilya, J. Nutr. Biochem. 2002, 13, 572-584.
46. D. F. Romagnolo, O. I. Selmin, J. Nutr. Gerontol. Geriatr. 2012, 31, 206-238.
47. A. Pick, H. Muller, R. Mayer, B. Haenisch, I. K. Pajeva, M. Weigt, H. Bonisch, C. E. Muller, M. Wiese, Bioorg. Med. Chem. 2011, 19, 2090-2102.
48. M. Pericleous, R. E. Rossi, D. Mandair, T. Whyand, M. E. Caplin, Anticancer Res. 2014, 34, 9-21.
49. R. Feng, Z. K. Guo, C. M. Yan, E. G. Li, R. X. Tan, H. M. Ge, Phytochemistry 2012, 76, 98-105.
50. S. Onishi, K. Nishi, S. Yasunaga, A. Muranaka, K. Maeyama, A. Kadota, T. Sugahara, J. Funct. Foods 2014, 6, 606-614.
51. A. L. Liu, H. D. Wang, S. M. Lee, Y. T. Wang, G. H. Du, Bioorg. Med. Chem. 2008, 16, 7141-7147.
52. D. D. Orhan, B. Ozcelik, S. Ozgen, F. Ergun, Microbiol. Res. 2010, 165, 496-504.
53. J. J. Cherry, A. Rietz, A. Malinkevich, Y. Liu, M. Xie, M. Bartolowits, V. J. Davisson, J. D. Baleja, E. J. Androphy, PLoS ONE 2013, 8, e84506.
54. S. Carradori, M. D'Ascenzio, P. Chimenti, D. Secci, A. Bolasco, Mol. Divers. 2014, 18, 219-243.
55. L. Huang, T. Su, X. Li, Curr. Top. Med. Chem. 2013, 13, 1864-1878.
56. E. W. Newcomb, Anticancer Drugs 2004, 15, 411-419.
57. K. C. Bible, P. P. Peethambaram, A. L. Oberg, W. Maples, D. L. Groteluschen, M. Boente, J. K. Burton, L. C. Gomez Dahl, J. D. Tibodeau, C. R. Isham, J. L. Maguire, V. Shridhar, A. K. Kukla, K. J. Voll, M. J. Mauer, A. D. Colevas, J. Wright, L. A. Doyle, C. Erlichman, Gynecol. Oncol. 2012, 127, 55-62.
58. M. G. Kelly, G. Mor, A. Husband, D. M. O'Malley, L. Baker, M. Azodi, P. E. Schwartz, T. J. Rutherford, Int. J. Gynecol. Cancer 2011, 21, 633-639.
59. J. B. Howes, P. L. de Souza, L. West, L. J. Huang, L. G. Howes, BMC Clin. Pharmacol. 2011, 11, 1.
60. C. M. Buchanan, J. H. Shih, J. W. Astin, G. W. Rewcastle, J. U. Flanagan, P. S. Crosier, P. R. Shepherd, Clin. Sci. (Lond.) 2012, 122, 449-457.
61. A. Kralj, M. T. Nguyen, N. Tschammer, N. Ocampo, Q. Gesiotto, M. R. Heinrich, O. T. Phanstiel, J. Med. Chem. 2013, 56, 5019-5032.
62. K. Mandery, B. Balk, K. Bujok, I. Schmidt, M. F. Fromm, H. Glaeser, Eur. J. Pharm. Sci. 2012, 46, 79-85.
63. M. E. Morris, S. Zhang, Life Sci. 2006, 78, 2116-2130.
64. W. Y. Feng, Curr. Drug Metab. 2006, 7, 755-809.
65. Y. Tayama, K. Sugihara, S. Sanoh, K. Miyake, S. Morita, S. Kitamura, S. Ohta, Drug Metab. Pharmacokinet. 2011, 26, 94-101.
66. Y. J. Moon, X. Wang, M. E. Morris, Toxicol. In Vitro 2006, 20, 187-210.
67. R. Cermak, Expert Opin. Drug Metab. Toxicol. 2008, 4, 17-35.
68. C. Johnson, C. Stubley-Beedham, J. G. Stell, Biochem. Pharmacol. 1985, 34, 4251-4256.
69. N. L. Allinger, J. Am. Chem. Soc. 1977, 99, 8127-8134.
70. M. J. S. Dewar, W. Thiel, J. Am. Chem. Soc. 1977, 99, 4907-4917.
71. R. Leardi, A. L. Gonzalez, Chemometrics Intell. Lab. Syst. 1998, 41, 195-207.
72. R. Leardi, J. Chemometrics 2000, 14, 643-655.